USPH
U.S. Physical Therapy Inc.
$73.74
$0.00(0.00%)
39
Overall
--
Value
--
Tech
39
Quality
Market Cap
$1.19B
Volume
103.37K
52W Range
$62.77 - $93.50
Target Price
$104.00
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $331.3M | $356.5M | $414.1M | $453.9M | $482.0M | $423.0M | $495.0M | $553.1M | $604.8M | $671.3M | ||
| Total Revenue | $331.3M | $356.5M | $414.1M | $453.9M | $482.0M | $423.0M | $495.0M | $553.1M | $604.8M | $671.3M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $78.4M | $82.0M | $90.6M | $101.7M | $112.5M | $94.5M | $117.2M | $112.0M | $121.5M | $123.9M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $215.8M | $235.0M | $276.6M | $305.2M | $324.1M | $282.3M | $330.3M | $370.9M | $426.5M | $482.4M | ||
| Research & Development | -- | -- | -- | -- | -- | -- | -- | -- | $15.0M | -- | ||
| Selling, General & Administrative | $35.2M | $36.5M | $39.6M | $46.0M | $49.9M | $46.7M | $51.8M | $51.7M | $58.1M | $65.2M | ||
| General & Administrative Expenses | $35.2M | $36.5M | $39.6M | $46.0M | $49.9M | $46.7M | $51.8M | $51.7M | $58.1M | $65.2M | ||
| Salaries & Wages | $180.5M | $198.5M | $237.1M | $259.2M | $274.2M | $235.6M | $278.5M | $319.2M | $353.4M | $399.4M | ||
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | -- | -- | -- | $17.9M | ||
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | -- | -- | -- | $17.9M | ||
| Amortization | -- | -- | -- | -- | -- | -- | -- | -- | -- | $17.9M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $47.3M | $49.5M | $54.7M | $60.3M | $67.4M | $52.4M | $70.6M | $56.8M | $52.1M | $63.2M | ||
| EBITDA | $48.1M | $46.9M | $38.2M | $56.0M | $63.8M | $58.7M | $67.7M | $59.4M | $56.5M | $65.1M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $1.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Intinc | $81.0K | $93.0K | $88.0K | $93.0K | $46.0K | $142.0K | $199.0K | $859.0K | $3.8M | $3.9M | ||
| Net Non-Operating Interest Income/Expense | $81.0K | $93.0K | $88.0K | $93.0K | $46.0K | $142.0K | $199.0K | $859.0K | $3.8M | $3.9M | ||
| Other Income/Expense | -- | -- | -- | $-1.8M | $-5.5M | $-1.1M | $-112.0K | $-2.0M | $-1.3M | $1.0M | ||
| Other Special Charges | -- | -- | -- | $1.8M | -- | -- | -- | $859.0K | $390.0K | $357.0K | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $211.0K | $131.0K | $599.0K | $-9.0K | $25.0K | $2.1M | $30.0K | -- | -- | -- | ||
| Special Income Charges | $-211.0K | $-131.0K | $-599.0K | $9.0K | $-25.0K | $-3.9M | $-2.6M | $-9.1M | $-17.5M | -- | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | $1.9M | -- | $9.1M | $17.5M | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $40.1M | $38.1M | $28.5M | $46.2M | $53.7M | $48.2M | $56.1M | $44.3M | $40.4M | $46.0M | ||
| Pre-Tax Income | $40.1M | $38.1M | $33.8M | $60.2M | $70.9M | $65.5M | $73.2M | $55.6M | $49.4M | $60.2M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $13.6M | $11.9M | $6.0M | $11.4M | $13.6M | $13.0M | $15.3M | $12.2M | $12.2M | $14.6M | ||
| NET INCOME | ||||||||||||
| Net Income | $20.6M | $20.6M | $22.3M | $34.9M | $40.0M | $35.2M | $40.8M | $32.2M | $28.2M | $31.4M | ||
| Net Income (Continuing Operations) | $26.5M | $26.3M | $22.5M | $34.9M | $40.0M | $35.2M | $40.8M | $32.2M | $28.2M | $31.4M | ||
| Net Income (Discontinued Operations) | $20.6M | $20.6M | $22.3M | $34.9M | $40.0M | $35.2M | $40.8M | $32.2M | $28.2M | $31.4M | ||
| Net Income (Common Stockholders) | $20.6M | $20.6M | $22.3M | $34.9M | $40.0M | $35.2M | $40.8M | $32.2M | $28.2M | $31.4M | ||
| Normalized Income | $26.3M | $24.9M | $22.5M | $47.6M | $50.5M | $54.6M | $60.5M | $53.0M | $56.5M | $62.0M | ||
| TOTALS | ||||||||||||
| Total Expenses | $215.8M | $235.0M | $276.6M | $305.2M | $324.1M | $282.3M | $330.3M | $370.9M | $426.5M | $482.4M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $12.4M | $12.5M | $12.6M | $12.7M | $12.8M | $12.8M | $12.9M | $13.0M | $14.2M | $15.1M | ||
| Average Shares Outstanding (Diluted) | $12.4M | $12.5M | $12.6M | $12.7M | $12.8M | $12.8M | $12.9M | $13.0M | $14.2M | $15.1M | ||
| Shares Outstanding | $12.5M | $12.6M | $12.7M | $12.8M | $12.8M | $12.9M | $13.0M | $13.0M | $15.1M | $15.2M | ||
| Basic EPS | $1.77 | $1.64 | $1.76 | $1.31 | $2.45 | $2.48 | $2.41 | $2.25 | $1.28 | $1.84 | ||
| Basic EPS (Continuing Operations) | $1.77 | $1.64 | $1.76 | $1.31 | $2.45 | $2.48 | $2.41 | $2.25 | $1.28 | $1.84 | ||
| Diluted EPS | $1.77 | $1.64 | $1.76 | $1.31 | $2.45 | $2.48 | $2.41 | $2.25 | $1.28 | $1.84 | ||
| Diluted EPS (Continuing Operations) | $1.77 | -- | -- | -- | -- | -- | -- | $2.25 | $1.28 | $1.84 | ||
| Dividend Per Share | $0.60 | $0.68 | $0.80 | $0.92 | $1.14 | $0.32 | $1.46 | $1.64 | $1.72 | $1.76 | ||
| OTHER METRICS | ||||||||||||
| Development Expense | -- | -- | -- | -- | -- | -- | -- | -- | $15.0M | -- | ||
| Earnings from equity interest | -- | -- | -- | -- | -- | -- | $112.0K | $1.2M | $955.0K | $1.0M | ||
| Earnings From Equity Interest Net Of Tax | -- | -- | -- | -- | -- | -- | $112.0K | $1.2M | $955.0K | $1.0M | ||
| Gain On Sale Of P P E | -- | -- | -- | -- | $5.5M | $1.1M | -- | -- | -- | -- | ||
| Minority Interests | $-5.9M | $-5.7M | $-244.0K | $-8.4M | -- | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | -- | -- | -- | -- | -- | $2.6M | -- | -- | -- | ||
| Other Gand A | $35.2M | $36.5M | $39.6M | $46.0M | $49.9M | $46.7M | $51.8M | $51.7M | $58.1M | $65.2M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | $2.4M | ||
| Restruct | $211.0K | $131.0K | $599.0K | $-9.0K | $25.0K | $2.1M | $30.0K | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | USPH | $73.74 | 0% | 103.37K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get U.S. Physical Therapy Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW